tiprankstipranks
Advertisement
Advertisement

AU:ALA Stock Latest News

Arovella Therapeutics Seeks ASX Quotation for 1.6 Million New Shares
Company AnnouncementsArovella Therapeutics Seeks ASX Quotation for 1.6 Million New Shares
1d ago
Arovella issues 1.6m new shares and affirms regulatory compliance
PremiumCompany Announcements
Arovella issues 1.6m new shares and affirms regulatory compliance
1d ago
Arovella Weighs Validity of Requisitioned Meeting for Board Appointments
PremiumCompany Announcements
Arovella Weighs Validity of Requisitioned Meeting for Board Appointments
1d ago
Arovella’s ALA-101 Trial Moves Toward Launch In CD19 Blood Cancers
PremiumCompany Announcements
Arovella’s ALA-101 Trial Moves Toward Launch In CD19 Blood Cancers
3d ago
ALA
Arovella’s Armoured CLDN18.2 CAR-iNKT Cells Show Strong Activity Against Gastric and Pancreatic Cancer In Vitro
PremiumCompany Announcements
Arovella’s Armoured CLDN18.2 CAR-iNKT Cells Show Strong Activity Against Gastric and Pancreatic Cancer In Vitro
10d ago
Arovella Wins TGA Green Light to Run ALA-101 Cell Therapy Trial Under Streamlined CTN Pathway
PremiumCompany AnnouncementsArovella Wins TGA Green Light to Run ALA-101 Cell Therapy Trial Under Streamlined CTN Pathway
26d ago
Arovella Therapeutics Announces Departure of Director Gary Phillips
Premium
Company Announcements
Arovella Therapeutics Announces Departure of Director Gary Phillips
2M ago
Arovella reshapes board as CAR-iNKT cell therapy program advances
Premium
Company Announcements
Arovella reshapes board as CAR-iNKT cell therapy program advances
2M ago
Arovella Steps Up Investor Outreach With Euroz Hartleys Forum and Roadshow
PremiumCompany Announcements
Arovella Steps Up Investor Outreach With Euroz Hartleys Forum and Roadshow
2M ago
Arovella Wins FDA IND Clearance as It Enters Clinical Stage With CAR-iNKT Cancer Therapy
PremiumCompany Announcements
Arovella Wins FDA IND Clearance as It Enters Clinical Stage With CAR-iNKT Cancer Therapy
2M ago
Arovella Wins FDA IND Clearance for Lead Cell Therapy ALA-101
PremiumCompany Announcements
Arovella Wins FDA IND Clearance for Lead Cell Therapy ALA-101
2M ago
Arovella Files IND for Lead CAR-iNKT Therapy as Cash Reserves Back 2026 Clinical Push
PremiumCompany Announcements
Arovella Files IND for Lead CAR-iNKT Therapy as Cash Reserves Back 2026 Clinical Push
3M ago
Arovella Therapeutics Names New Company Secretary and CFO to Support Growth
PremiumCompany AnnouncementsArovella Therapeutics Names New Company Secretary and CFO to Support Growth
3M ago
Arovella to Release 936,303 Escrowed Shares Issued for Investor Relations Services
Premium
Company Announcements
Arovella to Release 936,303 Escrowed Shares Issued for Investor Relations Services
3M ago
Arovella Seeks FDA Green Light for First-in-Human Trial of Lead CAR-iNKT Therapy
Premium
Company Announcements
Arovella Seeks FDA Green Light for First-in-Human Trial of Lead CAR-iNKT Therapy
3M ago
Arovella Therapeutics Issues New Shares to Bolster Cancer Therapy Development
PremiumCompany Announcements
Arovella Therapeutics Issues New Shares to Bolster Cancer Therapy Development
4M ago
Arovella Therapeutics Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Arovella Therapeutics Expands Market Presence with New Securities Quotation
4M ago
Arovella Therapeutics Director Adjusts Shareholding
PremiumCompany Announcements
Arovella Therapeutics Director Adjusts Shareholding
5M ago
Arovella Therapeutics Expands Share Issuance to Bolster Cancer Therapy Development
PremiumCompany Announcements
Arovella Therapeutics Expands Share Issuance to Bolster Cancer Therapy Development
5M ago
Arovella Therapeutics Announces Cessation of Securities
PremiumCompany AnnouncementsArovella Therapeutics Announces Cessation of Securities
5M ago
Arovella Therapeutics Expands Market Presence with New Securities Quotation
Premium
Company Announcements
Arovella Therapeutics Expands Market Presence with New Securities Quotation
5M ago
Arovella Therapeutics Announces Investor Presentation Update
Premium
Company Announcements
Arovella Therapeutics Announces Investor Presentation Update
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >